GRP
AVIR icon

Global Retirement Partners’s Atea Pharmaceuticals AVIR Stock Holding History

Global Retirement Partners’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$572 Buy
+123
New +$612 ﹤0.01% 4264
2024
Q4 		– Sell
-1,389
Closed -$4.65K – 3660
2024
Q3 		$4.65K Buy
+1,389
New +$5.04K ﹤0.01% 2593

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's AVIR Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Atea Pharmaceuticals (AVIR) in Q2 2026: 123 shares worth $572. The stake represents ﹤0.01% of the portfolio and ranks #4264 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AVIR as recently as Q3 2024.

Global Retirement Partners first reported a position in AVIR in Q3 2024 and has held it in 2 quarters since. The position peaked at $4.65K in Q3 2024. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Global Retirement Partners held 123 shares of Atea Pharmaceuticals worth $572 as of Q2 2026.
  • Atea Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Atea Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4264 holding.
  • Global Retirement Partners first reported a position in Atea Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
  • Global Retirement Partners's Atea Pharmaceuticals position peaked at $4.65K in Q3 2024.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.